DLBCL NOS

Clinical trials for DLBCL NOS explained in plain language.

Never miss a new study

Get alerted when new DLBCL NOS trials appear

Sign up with your email to follow new studies for DLBCL NOS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Engineered donor cells take on Hard-to-Treat lymphomas

Disease control Ongoing

This early-phase study tests a new treatment called P-CD19CD20-ALLO1 for people with certain types of B-cell lymphoma that have come back or not responded to standard therapy. The treatment uses donor immune cells that are specially designed to find and attack cancer cells. The m…

Matched conditions: DLBCL NOS

Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control

Last updated May 13, 2026 15:59 UTC

DLBCL NOS

Get alerted when new DLBCL NOS trials appear

Engineered donor cells take on Hard-to-Treat lymphomas